Bank of America’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $492K | Buy |
|
|||||
|
2025
Q1 | $402K | Sell |
|
|||||
|
2024
Q4 | $769K | Sell |
|
|||||
|
2024
Q3 | $1.24M | Buy |
|
|||||
|
2024
Q2 | $800K | Buy |
|
|||||
|
2024
Q1 | $294K | Sell |
|
|||||
|
2023
Q4 | $425K | Buy |
|
|||||
|
2023
Q3 | $316K | Buy |
|
|||||
|
2023
Q2 | $348K | Buy |
|
|||||
|
2023
Q1 | $143K | Buy |
|
|||||
|
2022
Q4 | $940 | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $21K | Buy |
|
|||||
|
2021
Q3 | $38K | Sell |
|
|||||
|
2021
Q2 | $124K | Sell |
|
|||||
|
2021
Q1 | $396K | Buy |
|
|||||
|
2020
Q4 | $49K | Buy |
|
|||||
|
2020
Q3 | $26K | Sell |
|
|||||
|
2020
Q2 | $243K | Buy |
|
|||||
|
2020
Q1 | $16K | Buy |
|